Literature DB >> 593659

Catecholamine content of the lacrimal fluid of healthy people and glaucoma patients.

T V Zubareva, Z M Kiseleva.   

Abstract

The level of catecholamines was determined in the lacrimal fluid since it may serve as an index of the activity of the sympatho-adrenal system. 86 persons aged between 35 and 65 years were studied. Of these, 49 were glaucoma patients, 16 patients had preglaucoma, and 21 practically healthy subjects served as a control. The results of the study showed that dopa and catecholamines: dopamine, noradrenaline and adrenaline can be determined in the lacrimal fluid of healthy people. Preglaucoma patients were found to have a reduced level of dopamine and its precursor dopa. Glaucoma patients were found to have reduced levels of dopa and noradrenaline. Determination of the level of catecholamine and dopa is considered to be an immediate index of the state of the sympathoadrenal system in the initial glaucoma. Determination of catecholamines and dopa in the lacrimal fluid can serve as a test in glaucoma diagnosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 593659     DOI: 10.1159/000308678

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

Review 1.  Wearable biosensors for healthcare monitoring.

Authors:  Jayoung Kim; Alan S Campbell; Berta Esteban-Fernández de Ávila; Joseph Wang
Journal:  Nat Biotechnol       Date:  2019-02-25       Impact factor: 54.908

2.  Catecholamine Detection Using a Functionalized Poly(l-dopa)-Coated Gate Field-Effect Transistor.

Authors:  Taira Kajisa; Wei Li; Tsuyoshi Michinobu
Journal:  ACS Omega       Date:  2018-06-20

3.  Dopamine levels in human tear fluid.

Authors:  Niyati Seshagiri Sharma; Suraj Kumar Acharya; Archana Padmanabhan Nair; Jyoti Matalia; Rohit Shetty; Arkasubhra Ghosh; Swaminathan Sethu
Journal:  Indian J Ophthalmol       Date:  2019-01       Impact factor: 1.848

4.  A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson's Disease and Parkinsonian Mice.

Authors:  Vsevolod Bogdanov; Alexander Kim; Marina Nodel; Tatiana Pavlenko; Ekaterina Pavlova; Victor Blokhin; Natalia Chesnokova; Michael Ugrumov
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.